Nogo-A expression in oligodendroglial tumors
- PMID: 20487307
- DOI: 10.1111/j.1440-1789.2010.01118.x
Nogo-A expression in oligodendroglial tumors
Abstract
Nogo-A belongs to the reticulon protein family and is expressed in the inner and outer loops of myelin sheaths of oligodendrocytes. We analyzed the patterns of Nogo-A expression in human gliomas in an effort to identify a useful marker for the characterization of oligodendroglial tumors. We determined the expression of Nogo-A in a panel of 58 astrocytic and oligodendroglial tumors using immunohistochemistry and compared the expression of Nogo-A with Olig-2, a recently identified marker for oligodendrogliomas. To localize Nogo-A expression, immunofluorescent staining was performed using other glial markers (MAP-2 and GFAP). We also confirmed the overexpression of the Nogo-A protein in 53 astrocytic and oligodendroglial tumors using Western blot analysis. Based on immunohistochemical analysis, Nogo-A and Olig-2 had specificity in the detection of oligodendroglial tumors from astrocytic tumors (P=0.001). The level of Nogo-A staining was highly correlated with Olig-2 (P=0.001). The sensitivity and specificity of Nogo-A for oligodendroglial tumors was 86.9% and 57.1%, respectively. Nogo-A expression overlapped that of other oligodendroglial markers, but with different patterns of expression. Western blot analysis revealed that Nogo-A is predominantly expressed in 85.7% of oligodendroglioma cells and 93.7% of anaplastic oligodendroglioma cells. Like other oligodendroglial markers, Nogo-A is highly expressed in oligodendroglial tumors; however, it does not serve as a definite marker specific for oligodendroglial tumors.
© 2010 Japanese Society of Neuropathology.
Similar articles
-
Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.Hum Pathol. 2012 Mar;43(3):374-80. doi: 10.1016/j.humpath.2011.05.007. Epub 2011 Aug 10. Hum Pathol. 2012. PMID: 21835431
-
Negative correlation of Nogo-A with the malignancy of oligodendroglial tumor.Neurosci Bull. 2007 Jan;23(1):41-5. doi: 10.1007/s12264-007-0006-1. Neurosci Bull. 2007. PMID: 17592524 Free PMC article.
-
Immunohistochemical comparative analysis of GFAP, MAP - 2, NOGO - A, OLIG - 2 and WT - 1 expression in WHO 2016 classified neuroepithelial tumours and their prognostic value.Pathol Res Pract. 2018 Jan;214(1):15-24. doi: 10.1016/j.prp.2017.12.009. Epub 2017 Dec 14. Pathol Res Pract. 2018. PMID: 29258767
-
Molecular pathology of oligodendroglial tumors.Recent Results Cancer Res. 2009;171:25-49. doi: 10.1007/978-3-540-31206-2_2. Recent Results Cancer Res. 2009. PMID: 19322536 Review.
-
Molecular pathways in the formation of gliomas.Glia. 1995 Nov;15(3):328-38. doi: 10.1002/glia.440150312. Glia. 1995. PMID: 8586467 Review.
Cited by
-
The isoform A of reticulon-4 (Nogo-A) in cerebrospinal fluid of primary brain tumor patients: influencing factors.Oncotarget. 2018 May 18;9(38):25048-25056. doi: 10.18632/oncotarget.25278. eCollection 2018 May 18. Oncotarget. 2018. PMID: 29861852 Free PMC article.
-
Distinct Specialized Center of Excellence, the Story of Hwasun Neurosurgery at Chonnam National University Hwasun Hospital.Brain Tumor Res Treat. 2023 Apr;11(2):94-102. doi: 10.14791/btrt.2023.0005. Brain Tumor Res Treat. 2023. PMID: 37151151 Free PMC article. Review.
-
Nogo-C contributes to HCC tumorigenesis via suppressing cell growth and its interactome analysis with comparative proteomics research.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2044-55. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24966913 Free PMC article.
-
The Overexpression of RTN4 Significantly Associated With an Unfavourable Prognosis in Patients With Lower-Grade Gliomas.J Cell Mol Med. 2025 Feb;29(4):e70418. doi: 10.1111/jcmm.70418. J Cell Mol Med. 2025. PMID: 39969103 Free PMC article.
-
Myelin-associated proteins are potential diagnostic markers in patients with primary brain tumour.Ann Med. 2021 Dec;53(1):1710-1721. doi: 10.1080/07853890.2021.1983205. Ann Med. 2021. PMID: 34601991 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous